| Autor: |
Dellino, Miriam, Cerbone, Marco, Laganà, Antonio Simone, Vitagliano, Amerigo, Vimercati, Antonella, Marinaccio, Marco, Baldini, Giorgio Maria, Malvasi, Antonio, Cicinelli, Ettore, Damiani, Gianluca Raffaello, Cazzato, Gerardo, Cascardi, Eliano |
| Přispěvatelé: |
Dellino, Miriam, Cerbone, Marco, Laganà, Antonio Simone, Vitagliano, Amerigo, Vimercati, Antonella, Marinaccio, Marco, Baldini, Giorgio Maria, Malvasi, Antonio, Cicinelli, Ettore, Damiani, Gianluca Raffaello, Cazzato, Gerardo, Cascardi, Eliano |
| Jazyk: |
angličtina |
| Rok vydání: |
2023 |
| Předmět: |
|
| Popis: |
One emerging problem for onco-gynecologists is the incidence of premenopausal patients under 40 years of age diagnosed with stage I Endometrial Cancer (EC) who want to preserve their fertility. Our review aims to define a primary risk assessment that can help fertility experts and onco-gynecologists tailor personalized treatment and fertility-preserving strategies for fertile patients wishing to have children. We confirm that risk factors such as myometrial invasion and The International Federation of Gynecology and Obstetrics (FIGO) staging should be integrated into the novel molecular classification provided by The Cancer Genome Atlas (TCGA). We also corroborate the influence of classical risk factors such as obesity, Polycystic ovarian syndrome (PCOS), and diabetes mellitus to assess fertility outcomes. The fertility preservation options are inadequately discussed with women with a diagnosis of gynecological cancer. A multidisciplinary team of gynecologists, oncologists, and fertility specialists could increase patient satisfaction and improve fertility outcomes. The incidence and death rates of endometrial cancer are rising globally. International guidelines recommend radical hysterectomy and bilateral salpingo-oophorectomy as the standard of care for this cancer; however, fertility-sparing alternatives should be tailored to motivated women of reproductive age, establishing an appropriate cost-benefit balance between childbearing desire and cancer risk. New molecular classifications such as that of TCGA provide a robust supplementary risk assessment tool that can tailor the treatment options to the patient's needs, curtail over- and under-treatment, and contribute to the spread of fertility-preserving strategies. |
| Databáze: |
OpenAIRE |
| Externí odkaz: |
|
